Net Worth Advisory Group’s Idexx Laboratories IDXX Stock Holding History

Net Worth Advisory Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$217K	Sell	412 -41	-9%	-$23K	0.05%	372
2026 Q1	$255K	Sell	453 -57	-11%	-$36.6K	0.05%	353
2025 Q4	$345K	Buy	510 +6	+1%	+$4.09K	0.07%	278
2025 Q3	$322K	Sell	504 -266	-35%	-$161K	0.09%	258
2025 Q2	$413K	Buy	770 +31	+4%	+$14.8K	0.09%	221
2025 Q1	$310K	Sell	739 -263	-26%	-$114K	0.1%	244
2024 Q4	$414K	Sell	1,002 -33	-3%	-$14.5K	0.13%	197
2024 Q3	$523K	Buy	+1,035	New	+$503K	0.16%	172

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Net Worth Advisory Group's IDXX Position: Q2 2026 in Review

Net Worth Advisory Group reduced its Idexx Laboratories (IDXX) stake by 9.1% in Q2 2026, selling an estimated $23K and leaving 412 shares worth $217K. The position accounts for 0.05% of the portfolio, ranked #372.

Net Worth Advisory Group first reported a position in IDXX in Q3 2024 and has held it in 8 quarters since. The position peaked at $523K in Q3 2024. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Net Worth Advisory Group held 412 shares of Idexx Laboratories worth $217K as of Q2 2026.
Net Worth Advisory Group sold 41 Idexx Laboratories shares in Q2 2026, an estimated $23K.
Idexx Laboratories made up 0.05% of Net Worth Advisory Group's portfolio in Q2 2026, its #372 holding.
Net Worth Advisory Group first reported a position in Idexx Laboratories in Q3 2024 and has held it in 8 quarters since.
Net Worth Advisory Group's Idexx Laboratories position peaked at $523K in Q3 2024.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Net Worth Advisory Group's 13F filing for Q2 2026, filed 14 Jul 2026.